Transplant Center Patient Navigator and Access to Transplantation among High-Risk Population: A Randomized, Controlled Trial

被引:38
|
作者
Basu, Mohua [1 ]
Petgrave-Nelson, Lisa [3 ]
Smith, Kayla D. [1 ,3 ]
Perryman, Jennie P. [3 ]
Clark, Kevin [3 ]
Pastan, Stephen O. [2 ,3 ]
Pearson, Thomas C. [1 ,3 ]
Larsen, Christian P. [1 ,3 ]
Paul, Sudeshna [4 ]
Patzer, Rachel E. [1 ,3 ,5 ]
机构
[1] Emory Univ, Sch Med, Dept Surg, Div Transplantat, 101 Woodruff Circle,5034 Woodruff Mem Res Bldg, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Div Renal, Atlanta, GA 30322 USA
[3] Emory Transplant Ctr, Atlanta, GA USA
[4] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Off Nursing Res, Atlanta, GA 30322 USA
[5] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA
关键词
clinical trial; transplant outcomes; risk factors; kidney transplantation; Humans; Living Donors; Patient Navigation; Proportional Hazards Models; Waiting Lists; Vulnerable Populations; Follow-Up Studies; kidney; Minority Groups; Transplants; Referral and Consultation; Social Class; DONOR KIDNEY-TRANSPLANTATION; STAGE RENAL-DISEASE; UNITED-STATES; RACIAL DISPARITIES; CONSENSUS CONFERENCE; DIALYSIS FACILITY; CLINICAL-TRIALS; CANCER CARE; DONATION; COMPLETION;
D O I
10.2215/CJN.08600817
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives Barriers exist in access to kidney transplantation, where minority and patients with low socioeconomic status are less likely to complete transplant evaluation. The purpose of this study was to examine the effectiveness of a transplant center-based patient navigator in helping patients at high risk of dropping out of the transplant evaluation process access the kidney transplant waiting list. Design, setting, participants & measurements We conducted a randomized, controlled trial of 401 patients (n=196 intervention and n=205 control) referred for kidney transplant evaluation (January 2013 to August 2014; followed through May 2016) at a single center. A trained navigator assisted intervention participants from referral to waitlisting decision to increase waitlisting (primary outcome) and decrease time from referral to waitlisting (secondary outcome). Time-dependent Cox proportional hazards models were used to determine differences in waitlisting between intervention and control patients. Results At study end, waitlisting was not significantly different among intervention (32%) versus control (26%) patients overall (P=0.17), and time from referral to waitlisting was 126 days longer for intervention patients. However, the effectiveness of the navigator varied from early (<500 days from referral) to late (500 days) follow-up. Although no difference in waitlisting was observed among intervention (50%) versus control (50%) patients in the early period (hazard ratio, 1.03; 95% confidence interval, 0.69 to 1.53), intervention patients were 3.3 times more likely to be waitlisted after 500 days (75% versus 25%; hazard ratio, 3.31; 95% confidence interval, 1.20 to 9.12). There were no significant differences in intervention versus control patients who started evaluation (85% versus 79%; P=0.11) or completed evaluation (58% versus 51%; P=0.14); however, intervention patients had more living donor inquiries (18% versus 10%; P=0.03). Conclusions A transplant center-based navigator targeting disadvantaged patients improved waitlisting but not until after 500 days of follow-up. However, the absolute effect was relatively small.
引用
收藏
页码:620 / 627
页数:8
相关论文
共 50 条
  • [1] A Patient Navigator Intervention to Reduce Hospital Readmissions among High-Risk Safety-Net Patients: A Randomized Controlled Trial
    Balaban, Richard B.
    Galbraith, Alison A.
    Burns, Marguerite E.
    Vialle-Valentin, Catherine E.
    Larochelle, Marc R.
    Ross-Degnan, Dennis
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2015, 30 (07) : 907 - 915
  • [2] A Patient Navigator Intervention to Reduce Hospital Readmissions among High-Risk Safety-Net Patients: A Randomized Controlled Trial
    Richard B. Balaban
    Alison A. Galbraith
    Marguerite E. Burns
    Catherine E. Vialle-Valentin
    Marc R. Larochelle
    Dennis Ross-Degnan
    [J]. Journal of General Internal Medicine, 2015, 30 : 907 - 915
  • [3] Randomized Controlled Trial to Prevent Infant Overweight in a High-Risk Population
    Reifsnider, Elizabeth
    McCormick, David P.
    Cullen, Karen W.
    Todd, Michael
    Moramarco, Michael W.
    Gallagher, Martina R.
    Reyna, Lucia
    [J]. ACADEMIC PEDIATRICS, 2018, 18 (03) : 324 - 333
  • [4] Yoga for high-risk pregnancy: A randomized controlled trial
    Deshpande, C. S.
    Rakshani, A.
    Nagarathna, R.
    Ganpat, T. S.
    Kurpad, A.
    Maskar, R.
    Nagendra, H. R.
    Sudheer, D. C.
    Abbas, R.
    Raghuram, N.
    Anura, K.
    Rita, M.
    Ramarao, N. H.
    [J]. ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2013, 3 (03) : 341 - 344
  • [5] A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population
    Lin, JT
    Yu, XZ
    Cui, DJ
    Chen, XY
    Zhu, JH
    Wang, YZ
    Wu, XD
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (01) : 75 - 82
  • [6] Chemoprevention of esophageal squamous cancer: Randomized, placebo-controlled trial in a high-risk population
    Limburg, P
    Wei, WQ
    Ahnen, D
    Qiao, YL
    Hawk, E
    Wang, GQ
    Giffen, C
    Roth, M
    Korn, E
    Dong, ZW
    Taylor, P
    Dawsey, S
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A71 - A71
  • [7] A randomized controlled trial of early physiotherapy for high-risk infants
    Weindling, AM
    Hallam, P
    Gregg, J
    Klenka, H
    Rosenbloom, L
    Hutton, JL
    [J]. ACTA PAEDIATRICA, 1996, 85 (09) : 1107 - 1111
  • [8] Topical tacrolimus for high-risk corneal transplantation: a randomized, clinical trial
    Shimazaki, Jun
    Tomida, Daisuke
    Yagi-Yaguchi, Yukari
    Satake, Yoshiyuki
    Yamaguchi, Takefumi
    [J]. BMC OPHTHALMOLOGY, 2024, 24 (01)
  • [9] A patient-tailored navigator program for colorectal cancer screening in a community health center: A randomized controlled trial
    Percac-Lima, S.
    Grant, R. W.
    Green, A.
    Ashburner, J.
    Gamba, G.
    Oo, S.
    Richter, J. M.
    Atlas, S. J.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 237 - 238
  • [10] A randomized-controlled trial of a patient-centred intervention in high-risk discharged older patients
    Arendts, Glenn
    Bullow, Kate
    Etherton-Beer, Christopher
    MacDonald, Ellen
    Dumas, Sandra
    Nagree, Yusuf
    Brown, Simon G. A.
    Almeida, Osvaldo P.
    [J]. EUROPEAN JOURNAL OF EMERGENCY MEDICINE, 2018, 25 (04) : 237 - 241